Yahoo Web Search

Search results

  1. The FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight.

  2. Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one...

  3. May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how...

    • Meg Tirrell
  4. Mar 19, 2024 · The drug semaglutide, sold commercially as Ozempic or Wegovy, is well known for helping people lose significant amounts of weight quickly. Now the U.S. Food and Drug Administration has approved...

  5. Nov 8, 2023 · But until now, Wegovy — also semaglutide but with a higher maximum dose than Ozempic — was the only approved drug that could safely elicit substantial weight loss in people with obesity...

  6. Mar 13, 2024 · On March 8, the FDA approved the use of Wegovy to reduce the risk of cardiovascular death, heart attack, and stroke in adults with heart disease with obesity or overweight. The indication ...

  7. People also ask

  8. Jun 4, 2021 · The FDA approved Wegovy, a drug doctors say could become the gold standard to treat obesity, a condition afflicting more than 40% adult Americans.

  1. People also search for